Skip to main content

Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research

Buy Article:

$43.00 plus tax (Refund Policy)

Background: Conflicts of interest arising from pharmaceutical industry sponsorship of clinical research have the potential to bias research outcomes and ultimately prejudice patient care. It is unknown how Australian Human Research Ethics Committees (HREC) assess and manage such conflicts of interest. We aimed to gain an understanding of how HREC approach the problem of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: clinical trial; conflict of interest; pharmaceutical sponsorship; research ethics; research ethics committee

Document Type: Research Article

Affiliations: Centre for Values Ethics and the Law in Medicine, University of Sydney, Sydney, New South Wales, Australia

Publication date: 2007-01-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more